{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:39:49Z","timestamp":1776699589065,"version":"3.51.2"},"reference-count":52,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"unspecified","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031315","name":"AstraZeneca UK Limited","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100031315","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,3,26]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine the risk of severe cardiovascular (CV) events in patients with chronic obstructive pulmonary disease (COPD) across different time periods following COPD exacerbations and the incidence rate of cardiopulmonary events in a real-world setting in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Regional electronic health records database from Yinzhou District of Ningbo City, China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>A total of 14\u2009713 patients aged \u226540 years with a first COPD diagnosis between 1 January 2014 and 1 March 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>The risk of severe CV events (ie, hospitalisation and a primary or secondary discharge code for acute coronary syndrome, heart failure decompensation, cerebral ischaemia, arrhythmia and CV-related death) during different exposed time periods following a COPD exacerbation, the incidence rate of overall cardiopulmonary events (ie, severe exacerbation of COPD, all-cause mortality, inpatient CV events, inpatient ischaemic stroke and inpatient tachyarrhythmia\/atrial fibrillation) and the incidence rate stratified by COPD exacerbation history.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included a total of 14\u2009713 patients. During a median (IQR) follow-up of 2.8 (4.0) years, 20.1% experienced severe CV events. Compared with the unexposed period, the risk of severe CV events was the highest in the first 10 days following a COPD exacerbation (adjusted HR 10.00, 95%\u2009CI 8.16 to 12.25). The risk of severe CV events decreased over time but remained significantly elevated up to 90 days post exacerbation. We found that 32.7% of COPD patients experienced cardiopulmonary events, with a crude incidence rate of 9.38 (95% CI 9.09 to 9.69) per 100 person-years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study is the largest retrospective cohort study investigating CV and cardiopulmonary events among patients with COPD in China. Our findings highlight an elevated risk of CV events closer to the time of COPD exacerbations and show that nearly one-third of COPD patients experience cardiopulmonary events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-109712","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:45:17Z","timestamp":1776696317000},"page":"e109712","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Risk of severe cardiovascular events and incidence rate of cardiopulmonary events among patients with COPD in China: a retrospective cohort study"],"prefix":"10.1136","volume":"16","author":[{"given":"Zhike","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iokfai","family":"Cheang","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, Jiangsu Province People\u2019s Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Shen","sequence":"additional","affiliation":[{"name":"Yinzhou District Centre for Disease Control and Prevention, Ningbo, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8332-7321","authenticated-orcid":false,"given":"Dongni","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Lin","sequence":"additional","affiliation":[{"name":"Yinzhou District Centre for Disease Control and Prevention, Ningbo, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7252-5349","authenticated-orcid":false,"given":"Siyan","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4334-6805","authenticated-orcid":false,"given":"Feng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanlin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital Fudan University, Shanghai, China"},{"name":"Shanghai Key Laboratory of Lung Inflammation and Injury, Department of Pulmonary Medicine, Zhongshan Hospital Fudan University, Shanghai, China"},{"name":"Shanghai Respiratory Research Institute, Shanghai, China"},{"name":"National Clinical Research Center for Aging and Medicine, Huashan Hospital Fudan University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6794-1468","authenticated-orcid":false,"given":"Xinli","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, Jiangsu Province People\u2019s Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"2026042007451182000_16.4.e109712.1","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2147\/COPD.S276819","article-title":"Management and Risk of Mortality in Patients Hospitalised Due to a First Severe COPD Exacerbation","volume":"15","author":"Janson","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026042007451182000_16.4.e109712.2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069679","article-title":"Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019","volume":"378","author":"Safiri","year":"2022","journal-title":"BMJ"},{"key":"2026042007451182000_16.4.e109712.3","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S161555"},{"key":"2026042007451182000_16.4.e109712.4","doi-asserted-by":"crossref","first-page":"859499","DOI":"10.3389\/fpubh.2022.859499","article-title":"The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019","volume":"10","author":"Yin","year":"2022","journal-title":"Front Public Health"},{"key":"2026042007451182000_16.4.e109712.5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2026042007451182000_16.4.e109712.6","doi-asserted-by":"crossref","unstructured":"Vogelmeier C , Simons S , Garbe E , et al . Increased risk of severe cardiovascular events following exacerbations of copd: a multi-database cohort study. Airway pharmacology and treatment. European Respiratory Society; September 9, 2023 doi:10.1183\/13993003.congress-2023.PA3013","DOI":"10.1183\/13993003.congress-2023.PA3013"},{"key":"2026042007451182000_16.4.e109712.7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2029"},{"key":"2026042007451182000_16.4.e109712.8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024350","article-title":"Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial","volume":"11","author":"Dransfield","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026042007451182000_16.4.e109712.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201711-2239OC"},{"key":"2026042007451182000_16.4.e109712.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.05.001"},{"key":"2026042007451182000_16.4.e109712.11","doi-asserted-by":"crossref","DOI":"10.1177\/1753465817750524","article-title":"Defining the relationship between COPD and CVD: what are the implications for clinical practice?","volume":"12","author":"Morgan","year":"2018","journal-title":"Ther Adv Respir Dis"},{"key":"2026042007451182000_16.4.e109712.12","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13620"},{"key":"2026042007451182000_16.4.e109712.13","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9435-7"},{"key":"2026042007451182000_16.4.e109712.14","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-023-02601-4","article-title":"Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands","volume":"24","author":"Swart","year":"2023","journal-title":"Respir Res"},{"key":"2026042007451182000_16.4.e109712.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-011-9301-8"},{"key":"2026042007451182000_16.4.e109712.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070022","article-title":"EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies","volume":"13","author":"Nordon","year":"2023","journal-title":"BMJ Open"},{"key":"2026042007451182000_16.4.e109712.17","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s12325-024-02855-4","article-title":"Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review","volume":"41","author":"Singh","year":"2024","journal-title":"Adv Ther"},{"key":"2026042007451182000_16.4.e109712.18","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S438893"},{"key":"2026042007451182000_16.4.e109712.19","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2023-323487"},{"key":"2026042007451182000_16.4.e109712.20","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1164\/rccm.202307-1122OC","article-title":"Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study","volume":"209","author":"Graul","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026042007451182000_16.4.e109712.21","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)61382-8"},{"key":"2026042007451182000_16.4.e109712.22","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1134\/S0006297916110134","article-title":"The role of cytokines in the development of atherosclerosis","volume":"81","author":"Fatkhullina","year":"2016","journal-title":"Biochemistry Moscow"},{"key":"2026042007451182000_16.4.e109712.23","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070781","article-title":"Inflammatory Mechanisms Contributing to Endothelial Dysfunction","volume":"9","author":"Theofilis","year":"2021","journal-title":"Biomedicines"},{"key":"2026042007451182000_16.4.e109712.24","first-page":"199","article-title":"Hypoxemia in patients with COPD: cause, effects, and disease progression","volume":"6","author":"Kent","year":"2011","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026042007451182000_16.4.e109712.25","doi-asserted-by":"crossref","first-page":"528789","DOI":"10.1155\/2014\/528789","article-title":"Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links","volume":"2014","author":"Laratta","year":"2014","journal-title":"Biomed Res Int"},{"key":"2026042007451182000_16.4.e109712.26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00975-2015"},{"key":"2026042007451182000_16.4.e109712.27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/COPD.S1516","article-title":"Cardiovascular morbidity and the use of inhaled bronchodilators","volume":"3","author":"Macie","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026042007451182000_16.4.e109712.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med"},{"key":"2026042007451182000_16.4.e109712.29","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S466280"},{"key":"2026042007451182000_16.4.e109712.30","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/915150","article-title":"Acid-base disorders in patients with chronic obstructive pulmonary disease: a pathophysiological review","volume":"2012","author":"Bruno","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"2026042007451182000_16.4.e109712.31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/COPD.S1401","article-title":"Mechanisms of atherothrombosis in chronic obstructive pulmonary disease","volume":"3","author":"Fimognari","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026042007451182000_16.4.e109712.32","doi-asserted-by":"crossref","first-page":"L151","DOI":"10.1093\/eurheartj\/suaa156","article-title":"Relapse of chronic obstructive pulmonary disease and myocardial infarction: what is the connection?","volume":"22","author":"Terrosu","year":"2020","journal-title":"Eur Heart J Suppl"},{"key":"2026042007451182000_16.4.e109712.33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amjcard.2024.06.005","article-title":"Atherosclerotic Coronary Plaque Features in Patients With Chronic Obstructive Pulmonary Disease and Acute Coronary Syndrome","volume":"224","author":"Russo","year":"2024","journal-title":"Am J Cardiol"},{"key":"2026042007451182000_16.4.e109712.34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.15326\/jcopdf.2022.0332","article-title":"Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial","volume":"10","author":"Wells","year":"2023","journal-title":"J COPD F"},{"key":"2026042007451182000_16.4.e109712.35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2147\/COPD.S350248","article-title":"Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population","volume":"17","author":"Sethi","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026042007451182000_16.4.e109712.36","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S346591"},{"key":"2026042007451182000_16.4.e109712.37","first-page":"6748330","article-title":"Intensive Intervention Improves Outcomes for Chronic Obstructive Pulmonary Disease Patients: A Medical Consortium-Based Management","volume":"2022","author":"Zhao","year":"2022","journal-title":"Can Respir J"},{"key":"2026042007451182000_16.4.e109712.38","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.21037\/jtd.2020.03.60","article-title":"Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients","volume":"12","author":"Aisanov","year":"2020","journal-title":"J Thorac Dis"},{"key":"2026042007451182000_16.4.e109712.39","doi-asserted-by":"crossref","unstructured":"Bhutani M , Cox J . Educating Cardiologists on COPD Management to Improve CVD Outcomes. Chest 2015;148. doi:10.1378\/chest.2230696","DOI":"10.1378\/chest.2230696"},{"key":"2026042007451182000_16.4.e109712.40","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S2213-2600(23)00261-8","article-title":"COPD and multimorbidity: recognising and addressing a syndemic occurrence","volume":"11","author":"Fabbri","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026042007451182000_16.4.e109712.41","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2023-002153","article-title":"Elucidating the risk of cardiopulmonary consequences of an exacerbation of COPD: results of the EXACOS-CV study in Germany","volume":"11","author":"Vogelmeier","year":"2024","journal-title":"BMJ Open Respir Res"},{"key":"2026042007451182000_16.4.e109712.42","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1038\/s41467-023-39638-4","article-title":"Swift and extensive Omicron outbreak in China after sudden exit from \u2018zero-COVID\u2019 policy","volume":"14","author":"Goldberg","year":"2023","journal-title":"Nat Commun"},{"key":"2026042007451182000_16.4.e109712.43","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01589-2020"},{"key":"2026042007451182000_16.4.e109712.44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12916-021-02000-w","article-title":"Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales","volume":"19","author":"Alsallakh","year":"2021","journal-title":"BMC Med"},{"key":"2026042007451182000_16.4.e109712.45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233147","article-title":"Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis","volume":"15","author":"Alqahtani","year":"2020","journal-title":"PLOS ONE"},{"key":"2026042007451182000_16.4.e109712.46","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2023-001698","article-title":"Burden of COPD in China and the global from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"10","author":"Li","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"2026042007451182000_16.4.e109712.47","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.arbres.2022.04.001","article-title":"COPD in China: Current Status and Challenges","volume":"58","author":"Liang","year":"2022","journal-title":"Arch Bronconeumol"},{"key":"2026042007451182000_16.4.e109712.48","unstructured":"World Health Organization . Advancing COPD care in China through a comprehensive approach. 2023."},{"key":"2026042007451182000_16.4.e109712.49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.46234\/ccdcw2020.063","article-title":"Distribution of Chronic Obstructive Pulmonary Disease","volume":"2","author":"Wang","year":"2014","journal-title":"China CDC Wkly"},{"key":"2026042007451182000_16.4.e109712.50","doi-asserted-by":"crossref","unstructured":"Kurmi O , Li L , Davis K , et al . Risk of cardiovascular events following copd hospitalisation: findings from the china kadoorie biobank cohort study. Eur Respir J 2015;46. doi:10.1183\/13993003.congress-2015.PA616","DOI":"10.1183\/13993003.congress-2015.PA616"},{"key":"2026042007451182000_16.4.e109712.51","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.01091-2024","article-title":"The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studies","volume":"11","author":"Nordon","year":"2025","journal-title":"ERJ Open Res"},{"key":"2026042007451182000_16.4.e109712.52","doi-asserted-by":"crossref","first-page":"00939","DOI":"10.1183\/23120541.00939-2025","article-title":"Long-term cardiovascular risk after severe exacerbation of COPD: a population-based cohort study","volume":"12","author":"Ding","year":"2026","journal-title":"ERJ Open Res"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-109712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:45:25Z","timestamp":1776696325000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-109712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,20]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjopen-2025-109712"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-109712","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}